Functional Effects of High Clopidogrel Maintenance Dosing in Patients With Inadequate Platelet Inhibition on Standard Dose Treatment

Updated guidelines on percutaneous coronary intervention recommend increasing the dose of clopidogrel to 150 mg in high-risk patients if

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2008-02, Vol.101 (4), p.440-445
Main Authors: Angiolillo, Dominick J., MD, PhD, Costa, Marco A., MD, PhD, Shoemaker, Steven B., MD, Desai, Bhaloo, PhD, Bernardo, Esther, BSc, Suzuki, Yoshie, MD, Charlton, Ronald K., PhD, Zenni, Martin M., MD, Guzman, Luis A., MD, Bass, Theodore A., MD
Format: Article
Language:English
Subjects:
Aged
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular
Diabetes Mellitus, Type 2 - blood
Dose-Response Relationship, Drug
Drug dosages
Effects
Female
Humans
Male
Medical sciences
Medical treatment
Middle Aged
Platelet Aggregation - drug effects
Platelet Aggregation Inhibitors - administration & dosage
Platelet Function Tests
Prescription drugs
Purinergic P2 Receptor Antagonists
Receptors, Purinergic P2Y12
Studies
Ticlopidine - administration & dosage
Ticlopidine - analogs & derivatives
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Updated guidelines on percutaneous coronary intervention recommend increasing the dose of clopidogrel to 150 mg in high-risk patients if
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2007.09.087